NEW ORLEANS, April 6, 2018 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that theyhave until May 7, 2018 to file lead plaintiff applications in a securities class action lawsuit against Henry Schein, Inc. (NasdaqGS: HSIC), if they purchased the Company's securities
Henry Schein investors should visit us at https://www.claimsfiler.com/cases/view-henry-schein-inc-securities-litigation or call to speak to our claim center toll-free at (844) 367-9658.
About the Lawsuit
Henry Schein and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On February 12, 2018, the Federal Trade Commission ("FTC") disclosed that it had filed a complaint against the Company for violating antitrust regulations through a conspiracy with other dental supply companies agreeing to refuse to offer discounts or service to buying groups representing dental practitioners.
On this news, the price of Henry Schein's shares plummeted $4.79 per share, or over 6.6%.
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. ClaimsFiler's team of experts monitor the securities class action landscape and cull information from a variety of sources to ensure comprehensive coverage across a broad range of financial instruments.
To learn more about ClaimsFiler, visit www.claimsfiler.com.
View original content:http://www.prnewswire.com/news-releases/henry-schein-shareholder-alert-claimsfiler-reminds-investors-with-losses-in-excess-of-100000-of-lead-plaintiff-deadline-in-class-action-lawsuit-against-henry-schein-inc---hsic-300625824.html
Subscribe to our Free Newsletters!
Lazy eye or amblyopia occurs when sight in one eye is less than the other in early childhood due to ...
Tracheal or windpipe cancer is a rare cancer and its cause is unclear. The most common squamous ...
Tecovirimat can be used to treat smallpox disease in adult and pediatric patients who weigh at ...View All